摘要
采用酶促培育法测定了８７例原发性肝癌病人血清醇脱氢酶（ｓＡＤＨ）活性，并与１７６例非肝病、非癌症病人、６６例正常人及７６例肝炎病人进行了比较，结果原发性肝癌病人ｓＡＤＨ活性显著高于非肝病、非癌症病人及正常人（Ｐ＜０．０１）；急、慢性肝炎病人ｓＡＤＨ活性也显著高于非肝病、非癌症病人及正常人（Ｐ＜０．０１）；非肝病、非癌症病人ｓＡＤＨ活性与正常人间无显著差异（Ｐ＞０．０５）。提示ｓＡＤＨ活性测定对于诊断原发性肝癌、肝炎具有器官特异性和疾病特异性。
The activity of serum ADH(sADH)in patients with primary liver cancer(PLC)was measured by an enzymological method,and was compared with that in 176 patients with benign diseases(non-hepatic or non-cancerous diseases),76 with hepatitis and 66 normals.The results showed that the sADH activity was significantly higher in the PLC patients than in the patients with benign diseases and the normals(P<0.01).The patients with hepatitis were also found to have significantly higher sADH activity(P<0.01).The patients with benigndiseases showed no difference from the normals(P>0.05).The above suggests the sADH activity shows an organic and disease specificity in diagnosis of PLC and hepatitis.
出处
《青岛医学院学报》
1994年第2期124-126,共3页
Acta Academiae Medicinae Qingdao Universitatis
